Alcyone Therapeutics



Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ l...

Ravi Mehrotra
Acting CFO & Head of Strategy
Ottavio Vitolo
Consulting CMO
Susan D'Costa
EVP, Technology Development
Gregory Stewart
EVP, Research & Development
Chris Coletta
VP, Program Management, Planning & Operations
Bryn Martin
VP, Research, Drug Delivery, & CSF Sciences
Deep Singh
VP, Business & Strategy, Drug Delivery
Andrew East
VP, Product Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.